TrialRespiratory research2020

Health-related quality of life and symptoms in patients with IPF treated with nintedanib: analyses of patient-reported outcomes from the INPULSIS® trials.

Michael Kreuter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.